ArticleJournal of health, population, and nutrition2026
Association of cumulative obesity- and insulin resistance-related indices with incident cardiovascular disease in Chinese middle-aged and elderly populations: a nationwide prospective cohort study.
Article in Journal of health, population, and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundObesity and insulin resistance (IR) are major contributors to cardiovascular disease (CVD). However, most studies have focused on single indices, and longitudinal evidence on multiple cumulative indices remains limited. This study aimed to systematically assess the associations between 18 cumulative obesity- and IR-related indices (OIRIs) and incident CVD in Chinese middle-aged and elderly adults, identifying the most predictive markers.
methodsA total of 2,124 participants from the China Health and Retirement Longitudinal Study (CHARLS) were included. Cumulative OIRIs were calculated as time-weighted averages from 2012 to 2015. The primary outcome was incident CVD, including heart disease and stroke, identified via self-report during follow-up from 2015 to 2020. Cox proportional hazards models were used to assess associations, while receiver operating characteristic (ROC) curves and restricted cubic spline (RCS) analyses evaluated predictive performance and dose–response relationships. Incremental predictive value beyond a base model was quantified using net reclassification improvement (NRI) and integrated discrimination improvement (IDI).
resultsDuring the follow-up period, 378 participants (17.80%) developed CVD. After adjusting for all covariates, eight cumulative OIRIs were significantly associated with CVD. Cumulative estimated glucose disposal rate (eGDR) was inversely associated with CVD risk (HR per SD increase = 0.683, 95% CI: 0.579–0.806). Seven other indices were positively associated with CVD risk: Chinese visceral adiposity index (CVAI), waist-to-height ratio (WHtR), body roundness index (BRI), triglyceride-glucose index (TyG), TyG-waist circumference (TyG-WC), TyG-waist-to-height ratio (TyG-WHtR), and lipid accumulation product (LAP) (all HRs > 1.10, P < 0.05). Cumulative eGDR demonstrated the highest predictive accuracy (AUC = 0.617), outperforming most other indices, followed by cumulative CVAI (AUC = 0.602). RCS models confirmed linear associations for all significant indices except the conicity index. Sex-stratified analyses showed stronger associations for eGDR (P-interaction = 0.024) and CVAI (P-interaction = 0.042) in males. Adding cumulative eGDR to traditional CVD risk models significantly improved prediction (AUC: 0.628→0.654; NRI = 0.285; IDI = 0.016; all P < 0.001).
conclusionsIn this national cohort, cumulative eGDR and CVAI were associated with incident CVD. Incorporating cumulative eGDR into traditional risk models was accompanied by modest improvements in discrimination and risk reclassification. These findings suggest that cumulative eGDR and CVAI may offer additional value for CVD risk stratification, although further studies with clinically adjudicated outcomes are warranted.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.